Trinity Biotech Reiterates Guidance To Achieve 2024 Sales Revenue For TrinScreen HIV Of Approximately $10M Trinity Biotech Reiterates Guidance To Achieve $20M Of Annualized Run-rate EBITDASO On ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback